Mayo Clinic researchers discovered it is safe — and much more convenient and less costly — for many patients to undergo coronary angiography and elective valve surgery on the same day, it is reported in the current issue of Mayo Clinic Proceedings.
A study showing that diabetic patients who are treated with long-term anti-clotting therapy are less likely to have a heart attack or die more than a year after stenting has been named among the best research papers presented at the 30th Annual Scientific Sessions of the Society for Cardiovascular Angiography and Interventions (SCAI), May 9?12, 2007.
Drug-eluting stents — small metal tubes used to prop open clogged arteries — have been garnering headlines. In an interview in the May issue of Mayo Clinic Women?s HealthSource, Abhiram Prasad, M.D., a Mayo Clinic cardiologist, puts recent developments in perspective.
Researchers at the University of Ottawa Heart Institute (UOHI) have identified a piece of the DNA sequence that boosts a person’s susceptibility to heart disease by up to 40 per cent regardless of other established risks such as cholesterol, blood pressure and diabetes. The discovery could help identify people at high future risk for heart disease, enabling early preventive therapies, including lifestyle changes and medication to reduce their risk. This finding may also lead to a better understanding of the biological pathways that lead to heart attacks.
A new study shows that aspirin therapy for coronary artery disease is four times more likely to be ineffective in women compared to men with the same medical history.
A new immunosuppression regimen for heart transplant patients can improve kidney function and prevent transplant coronary artery disease, according to two new Mayo Clinic studies. Mayo researchers will report their findings on April 26 at the International Society for Heart & Lung Transplantation Annual Meeting and Scientific Session in San Francisco.
A DEVICE that sounds like a 21st century version of a medicinal leech may soon be set loose inside the chests of heart patients. Resembling a robotic caterpillar, it will crawl across the surface of their beating heart, delivering treatment without the need for major surgery.
New Columbia University Medical Center research suggests a genomic test may provide detailed information on how well a transplanted heart is performing.
Mayo Clinic has designed a new system to speed critical care to acute heart attack patients that dramatically reduces the time that elapses before patients undergo a life-saving procedure — by as much as 45 percent in some cases.
Novartis announced that the United States has become the first country in the world to approve Tekturna? (aliskiren), the first new type of medicine in more than a decade for treating high blood pressure – a condition estimated to affect nearly one billion people worldwide and still uncontrolled in nearly 70% of patients.